Stay updated on Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section updated to clarify that publications are voluntarily provided and may be about the results, and that PubMed-derived publications are auto-filled; the revision version is updated to v3.3.2, replacing the previous language from v3.2.0.SummaryDifference0.4%

- Check28 days agoChange DetectedRemoved a notice about lapse in government funding and NIH Clinical Center operations. The page's core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedPage content remains focused on the NADIM trial details with no substantive updates. No new sections or deletions were detected between screenshots.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Adjuvant Nivolumab in Lung Cancer Clinical Trial page.